Correlation Between Dogwood Therapeutics, and BioAge Labs,

Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and BioAge Labs, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and BioAge Labs, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dogwood Therapeutics, and BioAge Labs,, you can compare the effects of market volatilities on Dogwood Therapeutics, and BioAge Labs, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of BioAge Labs,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and BioAge Labs,.

Diversification Opportunities for Dogwood Therapeutics, and BioAge Labs,

0.68

Correlation Coefficient

Dogwood Therapeutics,  BioAge Labs,

Poor diversification

The 3 months correlation between Dogwood and BioAge is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and BioAge Labs, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAge Labs, and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with BioAge Labs,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAge Labs, has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and BioAge Labs, go up and down completely randomly.

Pair Corralation between Dogwood Therapeutics, and BioAge Labs,

Given the investment horizon of 90 days Dogwood Therapeutics, is expected to generate 0.38 times more return on investment than BioAge Labs,. However, Dogwood Therapeutics, is 2.65 times less risky than BioAge Labs,. It trades about 0.06 of its potential returns per unit of risk. BioAge Labs, is currently generating about -0.11 per unit of risk. If you would invest  252.00  in Dogwood Therapeutics, on October 5, 2024 and sell it today you would earn a total of  9.00  from holding Dogwood Therapeutics, or generate 3.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Dogwood Therapeutics,  vs.  BioAge Labs,

Dogwood Therapeutics,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Dogwood Therapeutics, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dogwood Therapeutics, showed solid returns over the last few months and may actually be approaching a breakup point.

BioAge Labs,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioAge Labs, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Dogwood Therapeutics, and BioAge Labs,

The main advantage of trading using opposite Dogwood Therapeutics, and BioAge Labs, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, BioAge Labs, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAge Labs, will offset losses from the drop in BioAge Labs,'s long position.

The idea behind Dogwood Therapeutics, and BioAge Labs, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.